Hamlet BioPharma - Crunchbase Company Profile & Funding

Q: Where is Hamlet BioPharma's headquarters?

Hamlet BioPharma is located in Lund, Skane Lan, Sweden.

Q: Who invested in Hamlet BioPharma?

Hamlet BioPharma is funded by European Commission.

Q: When was the last funding round for Hamlet BioPharma?

Hamlet BioPharma closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Hamlet BioPharma raised to date?

Hamlet BioPharma has raised obfuscated.

Overview

Hamlet BioPharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Hamlet BioPharma

CB Rank

28243

Hamlet BioPharma is a pharmaceutical company with strong links to research.

Founded

obfuscation

Public

Post-IPO Equity

Lund, Skane Lan, Sweden

1-10

hamletpharma.com/

Biotechnology

Health Care

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Martin Erixon: CEO

Details

Legal Name

Hamlet Pharma AB

Also Known As

Hamlet Pharma

Operating Status

Active

Stock Symbol

FRA:7ZT

Company Type

For Profit

About the Company

Hamlet BioPharma is a pharmaceutical company with strong links to research, working with natural and biological substances.

Phone Number

+46 40 12 25 00

Contact Email

info@hamletpharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Alpha1H

A synthetic drug candidate that selectively kills tumor cells and is being developed for cancer treatment, including bladder and brain tumors.

BAMLET

A protein-lipid complex formed from bovine alpha-lactalbumin and oleic acid, under development for clinical trials targeting colon and oral cancers.

Research & Development

Hamlet BioPharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Hamlet BioPharma	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
European Commission	Yes	Grant - Hamlet BioPharma	—
European Commission	Yes	Grant - Hamlet BioPharma	—
European Commission	Yes	Grant - Hamlet BioPharma	—
European Commission	Yes	Grant - Hamlet BioPharma	—
European Commission	Yes	Grant - Hamlet BioPharma	—